What's New
Last Posted: Mar 05, 2020
- Heart Disease Family Health History, and Familial Hypercholesterolemia
CDC, March 2020 - Effect of Home Blood Pressure Monitoring via a Smartphone Hypertension Coaching Application or Tracking Application on Adults With Uncontrolled Hypertension- A Randomized Clinical Trial
SD Persell et al, JAMA Network Open, March 2, 2020 - Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease–Free Survival, and Mortality Risk- A Mendelian Randomization Analysis
B Arsenault et al, JAMA Network Open, February 27, 2020 - FDA approves bempedoic acid/ezetimibe for LDL lowering in ASCVD, HeFH
CM Ballantyne, Healio News, February 27, 2020 - Making Informed CHOICES: The Launch of a "Big Data" Pragmatic Trial to Improve Cholesterol Management and Prevent Heart Disease in Ontario.
Ferreira-Legere Laura E et al. Healthcare quarterly (Toronto, Ont.) 2020 Jan 22(4) 6-9 - Machine Learning and Deep Neural Networks Applications in Coronary Flow Assessment: The Case of Computed Tomography Fractional Flow Reserve.
Tesche Christian et al. Journal of thoracic imaging 2020 Feb - Screening for chronic conditions with reproductive factors using a machine learning based approach.
Tian Siyu et al. Scientific reports 2020 Feb 10(1) 2848 - The Potential Benefits of Deferred Payment for a Hypothetical Gene Therapy for Congestive Heart Failure: A Cost-Consequence Analysis.
Hlávka Jakub P et al. Applied health economics and health policy 2020 Feb - Translational Genomics in Neurocritical Care: a Review.
Myserlis Pavlos et al. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2020 Feb - Biological Versus Chronological Aging- JACC Focus Seminar
JACC Focus Seminar, February 2020 - Aspirin for Prevention of Cardiovascular Disease
AT Peters et al, JAMA Patient Page, February 18, 2020 - Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.
Limdi Nita A et al. The pharmacogenomics journal 2020 Feb - Do Polygenic Risk Scores Improve Patient Selection for Prevention of Coronary Artery Disease?
SS Khan et al, JAMA Editorial, February 18, 2020 - Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers.
Chaves-Markman Ândrea et al. Cureus 2020 Jan 12(1) e6530 - Genetic considerations for adults with congenital heart disease.
Ito Seiji et al. American journal of medical genetics. Part C, Seminars in medical genetics 2020 Feb - Pre-Test Probability and Genes and Variants of Uncertain Significance in Familial Long QT Syndrome.
Waddell-Smith Kathryn E et al. Heart, lung & circulation 2020 Jan - Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease.
Mosley Jonathan D et al. JAMA 2020 Feb 323(7) 627-635 - Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.
Elliott Joshua et al. JAMA 2020 Feb 323(7) 636-645 - A fitting machine learning prediction model for short-term mortality following percutaneous catheterization intervention: a nationwide population-based study.
Hsieh Meng-Hsuen et al. Annals of translational medicine 2019 Dec 7(23) 732 - Evaluation of machine learning methods to stroke outcome prediction using a nationwide disease registry.
Lin Ching-Heng et al. Computer methods and programs in biomedicine 2020 Feb 190105381
.png)
No hay comentarios:
Publicar un comentario